AllianceBernstein’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,040
Closed -$119K 3286
2025
Q1
$119K Hold
11,040
﹤0.01% 3040
2024
Q4
$141K Hold
11,040
﹤0.01% 3086
2024
Q3
$305K Hold
11,040
﹤0.01% 2910
2024
Q2
$320K Buy
11,040
+2,298
+26% +$109K ﹤0.01% 2889
2024
Q1
$390K Sell
8,742
-471
-5% -$20.2K ﹤0.01% 2693
2023
Q4
$357K Buy
9,213
+480
+5% +$17.3K ﹤0.01% 2769
2023
Q3
$257K Buy
8,733
+410
+5% +$19.5K ﹤0.01% 2874
2023
Q2
$529K Hold
8,323
﹤0.01% 2611
2023
Q1
$393K Buy
8,323
+850
+11% +$45.5K ﹤0.01% 2671
2022
Q4
$519K Hold
7,473
﹤0.01% 2611
2022
Q3
$1.1M Hold
7,473
﹤0.01% 2231
2022
Q2
$974K Hold
7,473
﹤0.01% 2360
2022
Q1
$755K Buy
+7,473
New +$905K ﹤0.01% 2518
2021
Q3
Sell
-5,000
Closed -$1.62M 3321
2021
Q2
$1.62M Buy
+5,000
New +$1.64M ﹤0.01% 2302

Other funds holding LYEL